Personalized smart voice-based electronic prescription for remote at-home feedback management in cardiovascular disease rehabilitation: a multi-center randomized controlled trial

• DOI: 10.3389/fpubh.2023.1113403
• Publication Date: 2023-06-06T19:39:46Z
• Authors: Yin-Hua Zhu; Li-Ping Xia; Jing Yan; Xiao-Ling Shou; Li-Yue Zhu; Yan Sun; Ju-Fei Wang; Xiao-Jun Ji; Mei-Li Zhu; Bei-Li Feng; Hua-Xian Chen
• Keywords: Disease management

Objective To investigate the quality and efficacy of remote at-home rehabilitation for patients with cardiovascular disease (CVD) using personalized smart voice-based electronic prescription, further explore standardized health management mode family cardiac rehabilitation. Trial design: A multicenter, randomized (1:1), non-blind, parallel controlled study. Methods total 171 CVD who were admitted to 18 medical institutions in China from April 2021 October 2022 randomly divided into a treatment group (86 cases) control (85 non-blinded experiment, based on sequence enrollment. The received routine training, feedback-based training. primary outcome was difference VO 2 peak (mL/min/kg) after 12 weeks. linear mixed model developed follow-up as dependent variable. Age baseline data utilized covariates, whereas hospital patient characteristics adjusted random-effect variables. As can accommodate missing under assumption random data, there no substitute value quantitative data. Results participants, 86 experimental 85 group, included main analysis. analysis, which used mixing model, revealed significant differences cardiopulmonary function indexes (VO /kg peak, AT, METs, maximum resistance) at different time (0, 4, weeks) ( p < 0.05). In values weeks; > (LS mean 1.49, 95%CI 0.09–2.89, = 0.037) other indicators 0.05) significantly between week 12. results comparable complete case Conclusion home prescription provides several benefits patients, including improvements muscle strength, endurance, function, aerobic metabolism. It also helps reduce risk factors enhances patients’ self-management abilities compliance. Clinical trial registration: http://www.chictr.org.cn , identifier ChiCTR2100044063.